[March 21, 2014]

Research and Markets: Biobetters Trends 2014 Report

Research and Markets (http://www.researchandmarkets.com/research/7l8gn8/biobetters_trends) has announced the addition of the "Biobetters Trends" report to their offering.

The report analyzes and presents an overview of Biobetters market worldwide. "Biobetters or Biosuperiors are novel molecules derived from successful, approved biologic products that have been customized to enhance its overall efficacy. The primary characteristics targeted by these applicants include extended half-life in human body, improved bioavailability, lower immunogenicity, higher purity, and fewer side-effects. These molecules contain the same active ingredients such as antibodies to target the same protein, but feature different chemical or molecular properties than the original drug."

The report further discusses about applications, future prospects, and comparison of biobetters with originator drugs and biosimilars along wit the strategic industry activities of major companies worldwide.

In addition, major companies operating in the Biobetters arena worldwide are profiled, including

- Amgen

- Cantab Biopharmaceuticals

- Crucell

- GreenCross

- Hanmi Pharm

- Medgenics

- PharmaEssentia

- Polytherics

- SynBio

- Teva Pharmaceutical Industries

- Xencor

... and others.

Key Topics Covered:

1. BIOBETTERS - A BIG TICKET OPPORTUNITY

A Prelude

Biobetters - A Better Bet

Originator Drugs vs. Biobetters

Biosimilars vs. Biobetters

2. MARKET TRENDS

An Evolution from Biotherapeutics to Biologics

Biobetter - The Gold Rush

Biotechnology Start-ups Focus on Biobetter Route

US Regulatory Scenario

3. RECENT INDUSTRY ACTIVITY

Synthon Takes Over Key Platforms of Biolex Therapeutics

Xencor Signs Agreement with Boehringer Ingelheim

Catalent Pharma Solutions Inks Agreement with Aptuit

Compass (News - Alert) Biotechnologies Establishes New Subsidiaries

Human Stem Cells Institute Announces SynBio Project

Lancaster Laboratories Enters into Partnership with BioAzure Technologies

Momenta Pharmaceuticals Inks Agreement with VirdantePharmaceuticals

PolyTherics Inks Agreement with DSM (News - Alert) BioSolutions

Watson Pharmaceuticals Acquires Eden Biopharm Group

4. MARKET PARTICIPANTS

5. APPENDIX

For more information visit http://www.researchandmarkets.com/research/7l8gn8/biobetters_trends

About Research and Markets

Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

[ Back To TMCnet.com's Homepage ]